Sun Pharmaceutical Sees Surge in Open Interest Amid Increased Derivatives Activity
Sun Pharmaceutical Industries Ltd has seen a notable rise in open interest, reaching 106,563 contracts, alongside a trading volume of 37,198 contracts. The stock has gained 0.33% today and has recorded five consecutive days of increases, with a market capitalization of Rs 4,11,234 crore.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened activity in the derivatives market. The latest open interest stands at 106,563 contracts, up from the previous figure of 94,807, marking a change of 11,756 contracts or a 12.4% increase. This surge coincides with a trading volume of 37,198 contracts, indicating robust participation in the stock's futures market.In terms of price performance, Sun Pharmaceutical has shown resilience, gaining 0.33% today, while the sector overall has returned 0.54%. The stock has been on an upward trajectory, recording gains for the past five consecutive days, with a total return of 1.81% during this period. Notably, the stock's performance is currently above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.
With a market capitalization of Rs 4,11,234 crore, Sun Pharmaceutical operates within the Pharmaceuticals & Biotechnology industry, showcasing a liquid trading environment with a delivery volume of 14.49 lakh shares, which has increased by 57.1% compared to the 5-day average. This data underscores the stock's active engagement in the market, reflecting its current standing without delving into future implications.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
